Jury Hands AstraZeneca Win In Nexium Pay-For-Delay Case
A Massachusetts federal jury sided with defendants AstraZeneca PLC and Ranbaxy Inc. in the first pay-for-delay class action trial since the U.S. Supreme Court agreed the patent settlements could face antitrust...To view the full article, register now.
Already a subscriber? Click here to view full article